Dr. Michael Raven, CEOis the CEO of Nualtis, where he drives the companyâs strategic direction and growth. He brings leadership experience from Bayer Pharmaceuticals, atai Life Sciences, and McKinsey & Company. With academic training in biotechnology, business, and innovation management, he is focused on advancing oral film drug delivery and building a high-performing team to improve therapeutic outcomes for humans and animals.